$BRZH
Breeze Holdings Acquisition Corp.

2024 Q4 Form 10-Q Financial Statement

#000121390024106113 Filed on December 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$260.1K
YoY Change -29.7%
Interest Expense $135.5K
YoY Change -18.62%
% of Operating Profit
Other Income/Expense, Net $2.438M
YoY Change -458.65%
Pretax Income $2.178M
YoY Change -307.47%
Income Tax -$12.04K
% Of Pretax Income -0.55%
Net Earnings $2.190M
YoY Change -303.4%
Net Earnings / Revenue
Basic Earnings Per Share $0.54
Diluted Earnings Per Share $0.54
COMMON SHARES
Basic Shares Outstanding 4.034M shares 4.034M shares
Diluted Shares Outstanding 4.034M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $102.5K
Receivables
Other Receivables
Total Short-Term Assets $193.1K
YoY Change -44.74%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $10.58M
YoY Change -16.63%
TOTAL ASSETS
Total Short-Term Assets $193.1K
Total Long-Term Assets $10.58M
Total Assets $10.77M
YoY Change -17.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.09M
YoY Change 33.63%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.09M
Total Long-Term Liabilities
Total Liabilities $13.64M
YoY Change 26.73%
SHAREHOLDERS EQUITY
Retained Earnings -$13.35M
YoY Change 30.19%
Common Stock $315.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$13.35M
YoY Change
Total Liabilities & Shareholders Equity $10.77M
YoY Change -17.38%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $2.190M
YoY Change -303.4%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
166547 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-22015739 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q3 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3140000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4318640 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2024Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
11.6
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
21208 shares
brez Warrants Exercisable Period After Completion Of Business Combination
WarrantsExercisablePeriodAfterCompletionOfBusinessCombination
P30D
CY2024Q3 brez Class Of Warrant Or Right Issue Price Of Warrants Or Rights Per Share
ClassOfWarrantOrRightIssuePriceOfWarrantsOrRightsPerShare
1
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q3 brez Business Combination Right Convertible Share Of Common Stock Conversion Ratio
BusinessCombinationRightConvertibleShareOfCommonStockConversionRatio
0.05 pure
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001817640
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2024Q3 brez Business Combination Right Convertible Share Of Common Stock Conversion Ratio
BusinessCombinationRightConvertibleShareOfCommonStockConversionRatio
0.05 pure
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2024#NonoperatingIncomeExpense
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2024#NonoperatingIncomeExpense
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39718
dei Entity Registrant Name
EntityRegistrantName
BREEZE HOLDINGS ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1849315
dei Entity Address Address Line1
EntityAddressAddressLine1
955 W. John Carpenter Freeway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100-929
dei Entity Address City Or Town
EntityAddressCityOrTown
Irving
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75039
dei City Area Code
CityAreaCode
(619)
dei Local Phone Number
LocalPhoneNumber
500-7747
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4033712 shares
CY2024Q3 us-gaap Cash
Cash
2 usd
CY2023Q4 us-gaap Cash
Cash
4228 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
102467 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
148953 usd
CY2024Q3 brez Prepayment Franchise Taxes Current
PrepaymentFranchiseTaxesCurrent
usd
CY2023Q4 brez Prepayment Franchise Taxes Current
PrepaymentFranchiseTaxesCurrent
57550 usd
CY2024Q3 brez Prepayment Income Taxes Current
PrepaymentIncomeTaxesCurrent
36689 usd
CY2023Q4 brez Prepayment Income Taxes Current
PrepaymentIncomeTaxesCurrent
36742 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
193064 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
266145 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
10578352 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
12977528 usd
CY2024Q3 us-gaap Assets
Assets
10771416 usd
CY2023Q4 us-gaap Assets
Assets
13243673 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
691277 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
206639 usd
CY2024Q3 brez Franchise Tax Payable
FranchiseTaxPayable
23229 usd
CY2023Q4 brez Franchise Tax Payable
FranchiseTaxPayable
usd
CY2024Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
87087 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
56270 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10086116 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8077415 usd
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3554250 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2200250 usd
CY2024Q3 us-gaap Liabilities
Liabilities
13640366 usd
CY2023Q4 us-gaap Liabilities
Liabilities
10277665 usd
CY2024Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
893712 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1159276 shares
CY2024Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
11.72
CY2023Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.91
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
10478352 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
12647701 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3140000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000 shares
CY2024Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
893712 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1159276 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
315 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
315 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13347617 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9682008 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-13347302 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9681693 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10771416 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13243673 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
260084 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
369952 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1844532 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1563416 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-260084 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-369952 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1844532 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1563416 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
135536 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
476103 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
387058 usd
CY2024Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2302250 usd
CY2023Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-846250 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-1354000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-2031000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2437786 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-679703 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-877897 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1643942 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2177702 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1049655 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2722429 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3207358 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12042 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26939 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33797 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2189744 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1076594 usd
us-gaap Net Income Loss
NetIncomeLoss
-2722429 usd
us-gaap Net Income Loss
NetIncomeLoss
-3241155 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4033712 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4033712 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4318640 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4318640 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4183686 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4183686 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4471096 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4471096 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9681693 usd
CY2024Q1 brez Common Stock Accretion To Redemption Value
CommonStockAccretionToRedemptionValue
-521132 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-32218564 usd
CY2024Q2 brez Common Stock Accretion To Redemption Value
CommonStockAccretionToRedemptionValue
-193135 usd
CY2024Q2 brez Equity Adjustment Related To Excise Taxes Payable
EquityAdjustmentRelatedToExciseTaxesPayable
30817 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
17103566 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-15338950 usd
CY2024Q3 brez Common Stock Accretion To Redemption Value
CommonStockAccretionToRedemptionValue
-198096 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2189744 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-13347302 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6531762 usd
CY2023Q1 brez Common Stock Accretion To Redemption Value
CommonStockAccretionToRedemptionValue
-173001 usd
CY2023Q1 brez Equity Adjustment Related To Excise Taxes Payable
EquityAdjustmentRelatedToExciseTaxesPayable
53959 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-654261 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-7412983 usd
CY2023Q2 brez Common Stock Accretion To Redemption Value
CommonStockAccretionToRedemptionValue
-123951 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1510300 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-9047234 usd
CY2023Q3 brez Common Stock Accretion To Redemption Value
CommonStockAccretionToRedemptionValue
-125875 usd
CY2023Q3 brez Equity Adjustment Related To Excise Taxes Payable
EquityAdjustmentRelatedToExciseTaxesPayable
2311 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1076594 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-10252014 usd
us-gaap Profit Loss
ProfitLoss
-2722429 usd
us-gaap Profit Loss
ProfitLoss
-3241155 usd
brez Interest And Unrealized Gain Loss On Investments
InterestAndUnrealizedGainLossOnInvestments
476103 usd
brez Interest And Unrealized Gain Loss On Investments
InterestAndUnrealizedGainLossOnInvestments
387058 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1354000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2031000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-68855 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-20852 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
508622 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
158682 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1850 usd
brez Increase Decrease In Franchise Taxes Payable
IncreaseDecreaseInFranchiseTaxesPayable
23229 usd
brez Increase Decrease In Franchise Taxes Payable
IncreaseDecreaseInFranchiseTaxesPayable
79648 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1243826 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1336181 usd
us-gaap Payments To Acquire Trust Preferred Investments
PaymentsToAcquireTrustPreferredInvestments
265433 usd
us-gaap Payments To Acquire Trust Preferred Investments
PaymentsToAcquireTrustPreferredInvestments
406790 usd
brez Cash Withdrawn From Trust Account To Redeeming Shareholders
CashWithdrawnFromTrustAccountToRedeemingShareholders
3081712 usd
brez Cash Withdrawn From Trust Account To Redeeming Shareholders
CashWithdrawnFromTrustAccountToRedeemingShareholders
5627006 usd
brez Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
59000 usd
brez Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
209650 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2875279 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5429866 usd
brez Proceeds From Short Term Working Capital Loan Related Party
ProceedsFromShortTermWorkingCapitalLoanRelatedParty
1180600 usd
brez Proceeds From Short Term Working Capital Loan Related Party
ProceedsFromShortTermWorkingCapitalLoanRelatedParty
1335400 usd
brez Proceeds From Promissory Note Related Party
ProceedsFromPromissoryNoteRelatedParty
265433 usd
brez Proceeds From Promissory Note Related Party
ProceedsFromPromissoryNoteRelatedParty
365473 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3081712 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5627006 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1635679 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3926133 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4226 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
167552 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4228 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14129 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
181681 usd
brez Non Cash Excise Taxes Payable
NonCashExciseTaxesPayable
30817 usd
brez Non Cash Excise Taxes Payable
NonCashExciseTaxesPayable
56270 usd
brez Accretion Of Common Stocks Subject To Redemption Value
AccretionOfCommonStocksSubjectToRedemptionValue
912363 usd
brez Accretion Of Common Stocks Subject To Redemption Value
AccretionOfCommonStocksSubjectToRedemptionValue
422827 usd
CY2020Q4 brez Sale Of Private Placement Warrants
SaleOfPrivatePlacementWarrants
5425000 shares
CY2020Q4 brez Class Of Warrant Or Right Issue Price Of Warrants Or Rights Per Share
ClassOfWarrantOrRightIssuePriceOfWarrantsOrRightsPerShare
1
CY2024Q3 brez Aggregate Fair Market Value Of Acquisition Threshold As Percentage Of Assets Held In Trust Account
AggregateFairMarketValueOfAcquisitionThresholdAsPercentageOfAssetsHeldInTrustAccount
0.80 pure
brez Minimum Voting Interest To Be Owned Or Acquired To Complete Business Combination
MinimumVotingInterestToBeOwnedOrAcquiredToCompleteBusinessCombination
0.50 pure
CY2020Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.15
CY2024Q3 brez Business Combination Minimum Threshold Limit Of Net Intangible Assets Required
BusinessCombinationMinimumThresholdLimitOfNetIntangibleAssetsRequired
5000001 usd
brez Restriction On Public Share Redemption In Case Of Stockholder Approval Of Business Combination
RestrictionOnPublicShareRedemptionInCaseOfStockholderApprovalOfBusinessCombination
0.10 pure
brez Business Combination Incomplete Percentage Of Stock Redemption
BusinessCombinationIncompletePercentageOfStockRedemption
1 pure
CY2024Q3 brez Business Combination Incomplete Maximum Dissolution Expenses To Be Paid
BusinessCombinationIncompleteMaximumDissolutionExpensesToBePaid
100000 usd
brez Assets Remaining Available For Distribution Per Share Maximum
AssetsRemainingAvailableForDistributionPerShareMaximum
11.16
CY2024Q3 us-gaap Cash
Cash
2 usd
CY2024Q3 brez Working Capital
WorkingCapital
9819425 usd
CY2020Q4 brez Proceeds From Sale Of Founder Shares
ProceedsFromSaleOfFounderShares
25000 usd
CY2020Q4 brez Proceeds From Unsecured And Non Interest Bearing Promissory Notes
ProceedsFromUnsecuredAndNonInterestBearingPromissoryNotes
300000 usd
CY2022Q3 brez Excise Tax Percentage
ExciseTaxPercentage
0.01 pure
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
509712 shares
CY2023Q1 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.56
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
5400000 usd
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
21208 shares
CY2023Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.77
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
231000 usd
CY2024Q2 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
265564 shares
CY2024Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
3100000 usd
CY2023Q1 brez Percentage Of Excise Tax On Redemption Amount Paid
PercentageOfExciseTaxOnRedemptionAmountPaid
0.01 pure
CY2024Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
87087 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
56270 usd
CY2023Q1 brez Percentage Of Excise Tax Liability Shares Redeemed
PercentageOfExciseTaxLiabilitySharesRedeemed
0.01 pure
us-gaap Use Of Estimates
UseOfEstimates
<p class="highlightCont" style="margin: 0px; text-indent: 0px; font-style: italic; font-size: 10pt; font-family: 'Times New Roman'; text-transform: none; font-variant: normal; line-height: 1.2;"><span style="font-weight: bold; line-height: inherit; font-size: 10pt;">Use of estimates</span></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-style: italic; font-size: 10pt; font-family: 'Times New Roman'; text-transform: none; font-variant: normal; line-height: 1.2;"><br/></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal; line-height: 1.2;"><br/></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to <span>one</span> or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p>
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
3076817 shares
CY2022Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1690196 shares
CY2024Q3 brez Business Combination Incomplete Maximum Dissolution Expenses To Be Paid
BusinessCombinationIncompleteMaximumDissolutionExpensesToBePaid
100000 usd
CY2024Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
10478352 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2189744 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1076594 usd
us-gaap Net Income Loss
NetIncomeLoss
-2722429 usd
us-gaap Net Income Loss
NetIncomeLoss
-3241155 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4033712 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4033712 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4318640 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4183686 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4183686 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4471096 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4471096 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-style: italic; font-size: 10pt; font-family: 'Times New Roman'; text-transform: none; font-variant: normal; line-height: 1.2;"><span style="font-weight: bold; line-height: inherit; font-size: 10pt;">Concentration of credit risk</span></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-style: italic; font-size: 10pt; font-family: 'Times New Roman'; text-transform: none; font-variant: normal; line-height: 1.2;"><br/></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times may exceed the Federal Deposit Insurance Corporation coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p>
us-gaap Concentration Risk Credit Risk Financial Instrument Maximum Exposure
ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
250000 usd
CY2023Q2 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-09-26
CY2023Q2 us-gaap Dividends Cash
DividendsCash
5000000 usd
CY2023Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-06-26
CY2023Q4 us-gaap Dividends Cash
DividendsCash
6000000 usd
CY2024Q2 brez Related Party Transaction Expenses Paid By Related Party On Behalf Of Company
RelatedPartyTransactionExpensesPaidByRelatedPartyOnBehalfOfCompany
202556 usd
CY2024Q3 brez Related Party Transaction Due To Related Party
RelatedPartyTransactionDueToRelatedParty
9284523 usd
CY2023Q3 brez Deposits Held In Trust Account
DepositsHeldInTrustAccount
40575 usd
CY2023Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.035
brez Percentage Of Advisor Cash Fee On Gross Proceeds Of Initial Public Offering
PercentageOfAdvisorCashFeeOnGrossProceedsOfInitialPublicOffering
0.0275 pure
brez Cash Fee For Advisory Services Upon Consummation Of Business Combination
CashFeeForAdvisoryServicesUponConsummationOfBusinessCombination
3162500 usd
CY2024Q3 brez Number Of Fractional Shares Issued Upon Exercise Of Public Warrant
NumberOfFractionalSharesIssuedUponExerciseOfPublicWarrant
0 shares
brez Warrants Exercisable Period From Closing Of Initial Public Offering
WarrantsExercisablePeriodFromClosingOfInitialPublicOffering
P12M
brez Warrant Expiration Period After Completion Of Business Combination Or Earlier Upon Redemption Or Liquidation
WarrantExpirationPeriodAfterCompletionOfBusinessCombinationOrEarlierUponRedemptionOrLiquidation
P5Y
CY2024Q3 brez Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
0 shares
CY2024Q3 brez Class Of Warrant Or Right Redemption Price
ClassOfWarrantOrRightRedemptionPrice
0.01
brez Minimum Period Of Prior Written Notice Of Redemption Of Warrants
MinimumPeriodOfPriorWrittenNoticeOfRedemptionOfWarrants
P30D
CY2024Q3 brez Minimum Price Per Share Required For Redemption Of Warrants
MinimumPricePerShareRequiredForRedemptionOfWarrants
18
brez Warrants Redemption Covenant Threshold Trading Days
WarrantsRedemptionCovenantThresholdTradingDays
P20D
brez Warrants Redemption Covenant Threshold Consecutive Trading Days
WarrantsRedemptionCovenantThresholdConsecutiveTradingDays
P30D
CY2024Q3 brez Maximum Effective Issue Price To Closing Of Business Combination
MaximumEffectiveIssuePriceToClosingOfBusinessCombination
9.2
CY2024Q3 brez Minimum Percentage Of Equity Proceeds From Issuances
MinimumPercentageOfEquityProceedsFromIssuances
0.60 pure
brez Number Of Trading Days Prior On Consummates Business Combination
NumberOfTradingDaysPriorOnConsummatesBusinessCombination
P20D
CY2024Q3 brez Maximum Effective Issue Price To Closing Of Business Combination
MaximumEffectiveIssuePriceToClosingOfBusinessCombination
9.2
CY2024Q3 brez Percentage Of Exercise Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price
PercentageOfExercisePriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice
1.15 pure
CY2024Q3 brez Minimum Price Per Share Required For Redemption Of Warrants
MinimumPricePerShareRequiredForRedemptionOfWarrants
18
brez Percentage Of Redemption Triggered Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price
PercentageOfRedemptionTriggeredPriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice
1.80 pure
brez Warrants Will Not Be Transferable Assignable Or Saleable Number Of Period After Completion Of Business Combination
WarrantsWillNotBeTransferableAssignableOrSaleableNumberOfPeriodAfterCompletionOfBusinessCombination
P30D
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5425000 shares
CY2024Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5425000 usd
CY2024Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2024Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2302250 usd
CY2023Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-846250 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-1354000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-2031000 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Holders of common stock are entitled to one vote for each share.
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3140000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000 shares
CY2024Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
893712 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1159276 shares
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1184750 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
169250 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1015500 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-1354000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2369500 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-846250 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3215750 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2200250 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-21132500 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
23332750 usd
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
17476250 usd
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
5856500 usd
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
2302250 usd
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3554250 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0055 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0257 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.011 pure
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure

Files In Submission

Name View Source Status
0001213900-24-106113-index-headers.html Edgar Link pending
0001213900-24-106113-index.html Edgar Link pending
0001213900-24-106113.txt Edgar Link pending
0001213900-24-106113-xbrl.zip Edgar Link pending
brez-20240930.htm Edgar Link pending
brez-20240930.xsd Edgar Link pending
ex311_1.htm Edgar Link pending
ex321_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
brez-20240930_lab.xml Edgar Link unprocessable
brez-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brez-20240930_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
brez-20240930_cal.xml Edgar Link unprocessable
brez-20240930_def.xml Edgar Link unprocessable